General Information
Version
8.4
Revision date
2025-03-25
Product name
Human iPSC Derived AFE Progenitors
1.2.1 Relevant identified uses
Biochemical research/analysis
Emergency telephone
+1-703-527-3887
Icons in SDS
Company Information
company name
MilliporeSigma Canada Ltd
Section 2
SECTION 2: Hazards identification
Not a hazardous substance or mixture according to Regulation (EC) No. 1272/2008. Classification of the substance or mixture
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher. Although the cell lines are not known to contain any agents capable of harm humans the possibility of a contaminant, adventitious virus can rarely be excluded. Therefore, it is recommended that all animal / human cell lines are handled at Biosafety Level 2 containment [United States Government Publication "Biosafety in Microbiological and Biomedical Laboratories (BMBL) 5th Edition" (CDC, 2009).] Human source: Appropriate safety procedure must be followed for human source material as found in: Laboratory Biosafety Guidelines, 3rd edition, 2004.
2.1 Classification of the substance or mixture
Not a hazardous substance or mixture according to Regulation (EC) No 1272/2008.
